Trial Profile
Effect of Imrecoxib on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Imrecoxib (Primary) ; Warfarin
- Indications Inflammation
- Focus Pharmacokinetics
- Sponsors Jiangsu Hengrui Medicine Co.
- 30 Apr 2015 New trial record